External Ventricular Drain Market Report 2026

External Ventricular Drain Market Overview

• External Ventricular Drain market size has reached to $4.99 billion in 2025 • Expected to grow to $6.74 billion in 2030 at a compound annual growth rate (CAGR) of 6.1% • Growth Driver: Rising Incidence Of Traumatic Brain Injuries Fuels Growth Of External Ventricular Drain Market • Market Trend: Advancements In Neurocritical Care Devices For Managing Intracranial Pressure • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under External Ventricular Drain Market?

External ventricular drain (EVD) refers to a medical device used to relieve elevated intracranial pressure (ICP) by draining cerebrospinal fluid (CSF) from the brain's ventricles to an external collection system. This helps prevent damage to brain tissues and alleviates symptoms such as headaches, nausea, and altered consciousness. This procedure is often utilized in patients with various disorders that lead to the accumulation of excess CSF within the cranial cavity. The main types of external ventricular drains are external ventricular drainage sets and accessories. An external ventricular drainage set refers to a medical device used to relieve elevated intracranial pressure by diverting cerebrospinal fluid from the brain's ventricles to an external collection system. It is used for various applications, such as traumatic brain injury, intracranial hemorrhage, hydrocephalus, and others, by several end users, including hospitals, specialty hospitals, specialty clinics, and others.

What Is The External Ventricular Drain Market Growth Forecast?

The external ventricular drain market size is expected to see strong growth in the next few years. It will grow to $6.74 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to rising burden of neurological disorders, growing demand for advanced neurocritical care, increasing investments in neurosurgery infrastructure, rising awareness of intracranial pressure management, expanding access to specialty neurological hospitals. Major trends in the forecast period include rising use of external ventricular drains in neurocritical care, growing adoption of adjustable and continuous evd systems, increasing demand for accurate intracranial pressure management, rising focus on infection control in cerebrospinal fluid drainage, growing utilization of evds in traumatic brain injury management.

What Is The Driver Of The External Ventricular Drain Market?

The increasing incidence of traumatic brain injuries (TBI) is expected to propel the growth of the external ventricular drain market going forward. Traumatic brain injury (TBI) refers to an injury to the brain caused by an external force, which can result in temporary or permanent impairment of cognitive, physical, and psychosocial functions. The increasing incidence of traumatic brain injuries can be attributed to factors including rising participation in contact sports, higher rates of motor vehicle accidents, and an aging population prone to falls. TBIs can generate elevated intracranial pressure (ICP) due to swelling, hemorrhage, or the collection of cerebrospinal fluid (CSF), all of which can result in additional brain damage. The external ventricular drain (EVD) helps to reduce these consequences by draining excess CSF and regularly monitoring ICP. For instance, in October 2023, according to the World Federation of Neurology, a UK-based organization committed to advancing neurological practice and research worldwide, more than 40% of the global population is affected by a neurological condition, a figure anticipated to nearly double by 2050. Therefore, the increasing incidence of traumatic brain injuries is driving the growth of the external ventricular drain industry.

Key Players In The Global External Ventricular Drain Market

Major companies operating in the external ventricular drain market are Medtronic Plc, B. Braun SE, Integra LifeSciences, Teleflex Incorporated, Spiegelberg GmbH & Co. KG, IRRAS AB, Sophysa, Raumedic AG, Luciole Medical AG, Fuji Systems Corporation, Ad-Tech Medical Instrument Corporation, Mizuho Medical Co. Ltd., Nipro Corporation, Kaneka Corporation, Samyang Biopharmaceuticals Corporation, Neuromedex GmbH, SILMAG S.A., Tokibo Co. Ltd., Well Lead Medical Co. Ltd., Beijing Xinlingwei Technology Co. Ltd.

Global External Ventricular Drain Market Trends and Insights

Major companies operating in the external ventricular drain market are focusing on developing innovative solutions such as neurocritical care devices to enhance patient outcomes, improve procedural efficiency, and address complex neurological conditions. A neurocritical care device is a medical device used to monitor and manage critically ill patients with severe neurological conditions, supporting functions like intracranial pressure monitoring and cerebrospinal fluid drainage. For instance, in March 2025, Anuncia Medical Inc., a US-based neurotherapeutic device company, received FDA Breakthrough Device Designation for its ReFlow External Ventricular Drains (EVD), a novel device designed to manage brain swelling and elevated intracranial pressure. The ReFlow EVD is the first of its kind to offer a noninvasive, manual flushing mechanism to restore and maintain cerebrospinal fluid (CSF) flow. It can be operated by nurses during routine patient checks, potentially reducing ICU stays, additional surgeries, and costly EVD replacements. This designation expands Anuncia's portfolio beyond hydrocephalus management into acute neurocritical care, enhancing patient outcomes and clinical workflows.

What Are Latest Mergers And Acquisitions In The External Ventricular Drain Market?

In June 2023, Luciole Medical AG, a Switzerland-based medical technology company, acquired Spiegelberg GmbH & Co. KG for an undisclosed amount. Through this acquisition, companies will integrate their product lines, manufacturing capabilities, and distribution networks to leverage their strengths, aiming to become leaders in next-generation brain monitoring devices. Spiegelberg GmbH & Co. KG is a Germany-based provider of catheters and external ventricular drainage kits.

What Defines the External Ventricular Drain Market?

The external ventricular drain market consists of sales of catheters, drainage systems, valve mechanisms, ICP monitors and transducers, and fixation devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the External Ventricular Drain Market Report 2026?

The external ventricular drain market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the external ventricular drain industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.